SANA

Sana Biotechnology, Inc.

5.51 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sana Biotechnology, Inc. stock is down -30.95% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 4 PUTs, 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 May 14:49 19 Jul, 2024 10.00 PUT 104 219
06 Jun 17:16 17 Jan, 2025 7.50 CALL 100 22
18 Jun 14:04 19 Jul, 2024 5.00 PUT 1644 452
18 Jun 15:26 19 Jul, 2024 5.00 PUT 856 452
18 Jun 16:32 21 Jun, 2024 7.50 PUT 200 1239

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus. SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease.